LabVantage Solutions Introduces LabVantage CORTEX, Advancing Its LIMS Platform for AI-Driven Laboratory Operations
5.3.2026 14:30:00 EET | Business Wire | Press release
LabVantage Solutions, Inc., a global provider of laboratory informatics solutions and services, today announced the launch of LabVantage CORTEX, a next-generation artificial intelligence (AI), analytics, and automation platform. The launch represents a strategic evolution of the company’s laboratory informatics portfolio, integrating advanced AI and smarter automation into the core LabVantage LIMS experience to help laboratories operate with greater accuracy, efficiency, and confidence.
LabVantage CORTEX is built to support the growing demand for intelligent, automated laboratory environments across industries, including pharma and biotech, food and beverage, oil and gas, forensics, and more. LabVantage CORTEX provides a customer-centric AI analytics and automation ecosystem that helps laboratories improve efficiency, reduce errors, and deepen data insights to accelerate R&D. This shift is timely, as a recent survey found that more than 75% of labs plan to implement AI and machine learning technologies within the next two years. LabVantage CORTEX complements and expands the capabilities of LabVantage LIMS, enabling more adaptive, self-optimizing lab environments.
“LabVantage CORTEX is more than just an upgrade; it is a fundamental reimagining of how laboratories interact with their data and processes,” said Gary Stimson, principal architect and head of AI technologies at LabVantage Solutions. “LabVantage CORTEX positions our customers at the forefront of laboratory innovation, enabling autonomous workflows, predictive quality control, and seamless regulatory compliance.”
A Platform Built for Modern Laboratory Automation
At the core of LabVantage CORTEX is a marriage between AI-driven innovation and the stable LIMS environment. LabVantage CORTEX is a multi-tenant, cloud-native platform where autonomous AI agents can orchestrate complex laboratory tasks inside the core LIMS. This approach allows laboratories to adopt rapid AI advancements without the downtime or risk of a full system upgrade.
By utilizing this cloud-native foundation, LabVantage provides a seamless, low risk migration path for existing customers. Designed as a cloud-native, Software-as-a-Service (SaaS)-based platform, LabVantage CORTEX integrates seamlessly with Internet of Things (IoT) devices and digital twin technologies to support real-time environmental monitoring, predictive maintenance, and proactive laboratory management. Together, these capabilities allow laboratories to remain agile, scalable, and prepared for future demands.
Mikael Hagstroem, chief executive officer of LabVantage Solutions, described LabVantage CORTEX as a proof point for the company's vision for an autonomous lab ecosystem where agentic AI enables scientists to focus on discovery, not routine tasks. He further stated, “LabVantage is committed to steadily improving LabVantage CORTEX with semantic capabilities, more agentic AI features, and seamless integration with new technologies. Our aim is to help customers speed up discovery and reach the market faster while supporting scientific advancement and operational efficiency.”
Intelligent Capabilities Delivering Measurable Impact
LabVantage CORTEX introduces a range of AI-enabled features designed to address persistent operational challenges, including:
- Worksheet assistance to help with data entry and analysis;
- Sample management assistance to simplify repetitive processes and optimize resources;
- Stability study assistance to monitor product trends and create protocols;
- Process simplification to help free up time for laboratory personnel; and
- Automated compliance monitoring aligned with FDA, EMA, and ISO standards.
These capabilities are intended to reduce manual effort, minimize errors, streamline workflows, and provide actionable insights across the laboratory lifecycle.
To explore how LabVantage CORTEX can optimize your laboratory operations, please visit www.labvantage.com, or meet LabVantage leaders at Pittcon 2026 (March 7-11) in San Antonio, TX (Henry B. González Convention Center, Booth #2837).
About LabVantage Solutions
A recognized leader in enterprise laboratory software solutions, LabVantage Solutions dedicates itself to improving customer outcomes by transforming data into knowledge. Its highly configurable, 100% browser-based platform consists of LIMS, ELN, LES, SDMS, and advanced analytics, supporting seamless deployment into any environment. Serving over 1,500 customers across life sciences, pharmaceuticals, biobanking, food & beverage, forensics, and more, LabVantage Solutions empowers innovation, helps improve product quality, and ensures compliance with industry regulations. Headquartered in Somerset, NJ, with offices worldwide, LabVantage Solutions has driven laboratory digital transformation for over 40 years. For more information, visit labvantage.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260305179077/en/
Contacts
Media Contact:
Charya Wickremasinghe, Ph.D.
Brandwidth Solutions LLC
cwickremasinghe@brandwidthsolutions.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alipay Launches Next-Generation AI Payment Infrastructure, Debuts AI Wallet and Token Pay to Power Agentic Economy26.5.2026 18:20:00 EEST | Press release
Alipay today introduced its full-stack AI payment solution to partners across industries, ranging from AI companies to traditional retailers, and debuted two new services — the world’s first AI Wallet and Token Pay — to support the agentic economy’s rapid growth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526337824/en/ Alipay Unveils Next-generation AI Payment Infrastructure This launch extends Alipay's next-generation AI payment infrastructure, building on its consumer-facing product Alipay AI Pay and its business-facing AI payment processing product. “While the essence of commerce remains unchanged in the age of AI, the emergence of AI agents is reshaping everything. Drawing on 22 years of technological expertise and commercial know-how, Alipay is building a new generation of AI payment services to accelerate the growth of the agentic commerce ecosystem,” said Cyril Han, CEO of Ant Group. AI Wallet: Giving Users Vis
Daiichi Sankyo Europe Reaffirms Commitment to Patient-Centred Care with Extensive Data Showcase at EAS Congress 202626.5.2026 18:00:00 EEST | Press release
Daiichi Sankyo Europe (DSE) is pleased to announce its extensive scientific presence at the European Atherosclerosis Society (EAS) Congress 2026. The presentation of 15 abstracts, comprising both clinical trial analyses and real-world evidence, underscores the company's sustained investment in cardiovascular health and its mission to care for every heartbeat. The 15-abstract showcase provides a comprehensive look at the role of bempedoic acid in lipid management. This includes post-hoc analyses in collaboration with Esperion Therapeutics from the Phase 3 CLEAR Outcomes trial exploring its impact on stroke and venous thromboembolism (VTE) incidence.5,6 There are also real-world findings from the MILOS registry, including a dedicated sub-analysis investigating the effectiveness of bempedoic acid across various background therapies.1,2,3,4 Results reinforce consistent effectiveness and safety profile of bempedoic acid across various EU countries and regardless of patients’ existing treatm
OpenRouter Raises $113 Million CapitalG-led Series B as Weekly Volume Explodes to 25T Tokens26.5.2026 16:15:00 EEST | Press release
OpenRouter, the AI model exchange, today announced a $113 million Series B led by Alphabet’s independent growth fund, CapitalG, with participation from investors including NVentures (NVIDIA’s venture capital arm), ServiceNow Ventures, MongoDB Ventures, Snowflake Ventures, Databricks Ventures, alongside existing investors including Andreessen Horowitz and Menlo Ventures. OpenRouter’s volume has surged to 25 trillion tokens per week (100 trillion tokens per month), representing a 5X increase from the 5 trillion tokens processed per week just six months ago. The explosion in token demand illustrates how quickly enterprises are deploying agents and scaling AI across multiple models and providers. OpenRouter’s infrastructure manages and optimizes inference and provides access to 400+ models across leading AI providers, including Anthropic, Google, OpenAI, xAI, and DeepSeek, among others. The platform is used by over 8 million global users, including AI-native startups and large enterprises,
Xsolla Expands Its Community Management Tools for Creators, Community Leaders, and Resellers26.5.2026 16:00:00 EEST | Press release
Xsolla, a leading global video game commerce company, today announced three simultaneous expansions of its community management tools and products. As the creator economy continues to reshape how games are discovered and the industry accelerates its shift toward direct-to-consumer commerce, Xsolla is building on its community management tools for creators, community leaders, and emerging markets, and will showcase them at TwitchCon Rotterdam later this month. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526596720/en/ Graphic: Xsolla The games industry has never had a shortage of people who drive player acquisition, loyalty, and commerce; it's had a shortage of infrastructure that recognizes them. Creators stream it. Community leaders build a culture around it. Local resellers get it into the hands of players in markets traditional channels can't reach. Each operates at the center of how games are discovered, adopted, an
Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure26.5.2026 15:00:00 EEST | Press release
Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platforms, RenSuper establishes a closed-loop antibody discovery engine combining in vivo immune repertoires, AI-driven candidate selection, automated experimental validation, and scalable manufacturing infrastructure. The platform supports the discovery and development of monoclonal antibodies, bispecifics, multispecifics, antibody-drug conjugates (ADCs), VHHs, and other advanced therapeutic modalities, significantly reducing the time and risk associated with antibody discovery. RenSuper Workstation: AI-Powered One-Click Tar
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom